Strategies for Incorporating Immunotherapy in Advanced Breast Cancer

Faculty: Barbara Pockaj, MD, George Plitas, MD, Rita Nanda, MD, Elizabeth Mittendorf, MD and Brian Czerniecki, MD.

This interview-based enduring material is comprised of four separate, but complementary interviews designed to review current immunotherapy treatment options available and in development, and describe how the tumor immune microenvironment may clinically impact patients with breast cancer. This enduring material is supported by an independent educational grant from Merck.

Find this activity in the Breast Disease section of the ExpertED@SSO catalog.

Moderator: Martin D. Fleming, MD, PhD

Faculty: Christina L. Roland, MD, Ricardo J. Gonzalez, MD and Andrew J. Bishop, MD

Optimal integration of radiation into multi-modality therapy for soft tissue sarcoma requires understanding the risk and benefits of radiation, stratification of local recurrence risk and understanding which patients are candidates for treatment. This webinar will increase knowledge in these areas and help you better assess patients most likely to benefit from therapy with IMRT, IGRT or proton beam.

Register today at ExpertED@SSO.

Faculty: Richard White, Jr., MD, Genevieve Boland, MD, PhD, Mary Sue Brady, MD and Jeffrey Sosman, MD

The staging of melanoma has changed and has impact on care decisions, which have evolved across disease stages. Participants in this program will be better able to identify changes in the staging system and understand adjuvant treatment options and proper indications related to BRAF negative patients.

You may find this activity in the Melanoma Disease section of the ExpertED@SSO catalog.

Faculty: Monica Morrow, MD, Armando Giuliano, MD, and Melissa Pilewskie, MD

Options for managing the axillary nodes in patients with breast cancer vary based on clinical presentation, planned surgical procedure and timing of surgery and chemotherapy. This webinar will explain when axillary dissection is indicated for nodal metastases, when sentinel node biopsy alone is appropriate and how to identify patients most likely to avoid axillary dissection using neoadjuvant therapy.

You may find this activity in the Breast Disease section of the ExpertED@SSO catalog.

Faculty: Tracy S. Wang, MD, MPH, FACS

As management of indeterminate thyroid nodules evolves, the need for greater knowledge of testing options and cytological reporting increases. Participants in this webinar will be better able to discuss the Bethesda system for reporting thyroid cytology and not only identify molecular testing options, but also be able to determine optimal utilization of them.

You may find this activity in the Endocrine/Head and Neck Disease section of the ExpertED@SSO catalog.

This series of five topics will cover minimally invasive approaches utilizing robotics for a variety of gastrointestinal procedures with video recordings and faculty discussion.  Topics include: training in robotic surgical oncology and robotics in liver, pancreas, esophageal and gastric surgery. This series of activities is partially supported by Ethicon.

You may find this activity in the Gastrointestinal Disease section of the ExpertED@SSO catalog.

Faculty: Matthew Weiss, MD and Flavio Rocha, MD. Moderated by Alexander Parikih, MD, MPH

Irreversible electroporation (IRE) is a new technique that has been utilized in the treatment of different cancers. In Pancreas cancer, IRE has been used to treat locally advanced, non-resectable disease and to improve margins in resectable patients. As the technique evolves, surgeons need to be familiar to the pros and cons of the technique and its potential role in the treatment of pancreatic cancer. Hear both sides of the debate with case-based discussions.

You may find this activity in the Hepato-pancreato-biliary Disease section of the ExpertED@SSO catalog.

Faculty: Sandra L. Wong, MD, lead author of the Guideline, and Guideline co-authors, Keith Delman, MD, Jonathan Zager, MD and Charlotte Ariyan, MD

Sentinel lymph node (SLN) biopsy has been found to be useful for intermediate-thickness melanoma, based on results from a meta-analysis that showed low false-negative rates and high rates of sentinel node detection. New data from randomized clinical trials inform the evolution of SLN biopsy. This webinar covers important information and updates from the joint ASCO-SSO Melanoma Clinical Practice Guideline, “Sentinel Lymph Node Biopsy and Management of Regional Lymph Nodes in Melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Clinical Practice Guideline Update” that was published in February 2018.

You may find this activity in the Melanoma Disease section of the ExpertED@SSO catalog.